• Keine Ergebnisse gefunden

Literaturverzeichnis zum Titelthema „

N/A
N/A
Protected

Academic year: 2022

Aktie "Literaturverzeichnis zum Titelthema „"

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Literaturverzeichnis zum Titelthema „Operative Intensivmedizin – highlighted“

von Dr. Charlotte Lingg, Dr. Silja Kriescher und Universitätsprofessor Dr. Gerhard Schneider Bayerisches Ärzteblatt 3/2020, Seite 80 ff.

1. Marcantonio ER. Delirium in Hospitalized Older Adults. N Engl J Med 2017;377:1456–

1466.

2. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines; 1993.

https://www.who.int/classifications/icd/en/bluebook.pdf.

3. Nikooie R., Chessare C., Needham DM. PADIS Guidelines Teaching Slides: Delirium.

https://www.sccm.org/ICULiberation/Resources/PADIS-Guidelines-Teaching-Slides- Delirium (accessed 21. Oktober 2019).

4. Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al.

Clinical Practice Guidelines for the Prevention and Management of Pain,

Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Critical Care Medicine 2018;46:e825-e873.

5. Park SY, Lee HB. Prevention and management of delirium in critically ill adult patients in the intensive care unit: a review based on the 2018 PADIS guidelines. Acute and critical care 2019;34:117–125.

6. Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med 2018;379:2506–

2516.

7. Barnes-Daly MA, Phillips G, Ely EW. Improving Hospital Survival and Reducing Brain Dysfunction at Seven California Community Hospitals: Implementing PAD Guidelines Via the ABCDEF Bundle in 6,064 Patients. Critical Care Medicine 2017;45:171–178.

8. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest

Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–1655.

9. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001

SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 2003;31:1250–1256.

10. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al.

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

JAMA 2016;315:801–810.

11. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock:

2016. Critical Care Medicine 2017;45:486–552.

12. Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update.

Intensive care medicine 2018;44:925–928.

13. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. The New England journal of medicine 2008;358:877–887.

14. Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al.

Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. The New England journal of medicine 2018;378:809–818.

15. Fowler AA, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in

Patients With Sepsis and Severe Acute Respiratory Failure. JAMA 2019;322:1261.

16. Prien T. Die Patientenverfügung: der Arzt in der Entscheidung. In: Deutsche Akademie f.

Anästhesiologische Fortbildung DAfA (ed). Refresher Course Nr. 41/2015: Aktuelles Wissen für Anästhesisten. Ebelsbach: Aktiv Druck & Verlag GmbH; 2015.

(2)

17. Fleischmann-Struzek C, Mikolajetz A, Reinhart K, Curtis RJ, Haase U, Thomas-Rüddel D, et al. Hospitalisierung und Intensivtherapie am Lebensende: Eine nationale Analyse der DRG-Statistik zwischen 2007 und 2015. Deutsches Aerzteblatt 2019;116:653–660.

18. Bender A. S1-Leitlinie Hypoxisch-ischämische Enzephalopathie im Erwachsenenalter;

2018. www.dgn.org/leitlinien (accessed 22. August 2019).

19. Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin, Deutsche

Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin. S3-Leitlinie Analgesie, Sedierung und Delirmanagement in der Intensivmedizin -Addendum-. 2015.

www.awmf.org; Registernummer 001-012

20. Vincent JL, Moreno R, Takala J, Willatts S, Mendonça A de, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.

On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–710.

Referenzen

ÄHNLICHE DOKUMENTE

Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care

All continuous variables were non-normally distributed, are presented as median (range) and were compared using Mann-Whitney-U tests; categorical variables are presented as n (%)

Internally implies that the monitor is employed at the Department of Intensive Care Medicine, University Hospital of Bern (Inselspital), but carries out the monitoring independently,

Montejo JC, Grau T, Acosta J Ruiz-Santana S, Planas M, Garcia-De-Lorenzo A, Mesejo A, Cervera M, Sanchez-Alvarez C, Nunez-Ruiz R, Lopez-Martinez J : Nutritional and Metabolic

Eine feste Transporteinrichtung (Abb. 2) vermeidet akzidentelle Schäden sowohl am Patienten als auch am Gerät und sollte daher bei jedem Transport zu Verfügung stehen [45,46]. So

Dies bedeutet, dass der im Einzelfall nicht vorhersehbare Risikoeintritt (hier: Intensiv be hand lung) und der nicht vorher bestimmbare Bedarf an Mitteln (hier: Kosten

Purpose of Review Delirium in the intensive care unit (ICU) has become increasingly acknowledged as a significant problem for critically ill patients affecting both the actual

Alendronate treatment reduced the risk of clinical fractures Table 2 Summary of available drugs for use in fracture prevention in osteoporosis Drugs Dosage Approved GFR cut-off,